Status:
RECRUITING
Hot Flashes and Neurovascular Function in Women
Lead Sponsor:
Mayo Clinic
Collaborating Sponsors:
National Institutes of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
Conditions:
Hot Flashes
Menopause
Eligibility:
FEMALE
40-60 years
Phase:
NA
Brief Summary
Women who experience hot flashes are at greater risk for hypertension and other cardiovascular disease. Neurovascular control mechanisms are likely to play an important role in this relationship. As s...
Eligibility Criteria
Inclusion
- Non-smokers.
- Non-obese.
- Have at least one ovary.
- Free from cardiovascular disease.
- Not taking medications influencing cardiovascular function.
Exclusion
- \- None.
Key Trial Info
Start Date :
February 24 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2026
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT05193968
Start Date
February 24 2022
End Date
December 1 2026
Last Update
June 3 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic in Rochester
Rochester, Minnesota, United States, 55905